Inhibition of ATR and PKMYT1 induces synthetic lethality in RB1-deficient #BreastCancer. Important implications for pts resistant to CDK4/6 inhibitors. @mdanderson.bsky.social #EndCancer
www.science.org/doi/10.1126/...
ATR/PKMYT1 coinhibition induces synthetic lethality in Rb1-deficient breast cancers, supporting biomarker-guided therapy.